US Patent Issued to CHENGDA PHARMACEUTICALS on Sept. 9 for "Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,131, issued on Sept. 9, was assigned to CHENGDA PHARMACEUTICALS Co. LTD. (Jiaxing, China).

"Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone" was invented by Yu Feng (Jiaxing, China), Hong Xu (Jiaxing, China), Jiaxuan Wu (Jiaxing, China), Danhui Song (Jiaxing, China), Weihui Zhong (Jiaxing, China), Fei Ling (Jiaxing, China) and Chao Xu (Jiaxing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of drug synthesis, and discloses a method for the preparation of trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as an int...